Table 1.

Correlation of qRT-PCR, FISH, RT-PCR, and IHC

Cases3′/5′aFISHRT-PCRIHCPathol.
78249.5PV3a/bA
98164.8PE17b ins 39;A20A
65478.4PNA
460241.3PV1A
1,47463.1PN+A
39978.2PV3a/b+A
490130.6PV3a/b+A
636300.2PV1+A
667556.4PV1+A
93867.1PN+AS
83432.2PV1++A
73236.7PV2++A
98839.6PE10a/b, E13;A20++A
78851.6PV3a/b++A
1,33583.2PV1++A
1,00488PV1++A
781103.2PV3b++A
1,003121.9PV1++AS
578494.6PV1++A
81101.1PN+++A
1,514109.9PV1+++A
737145.4PE17 ins 65;A20+++A
877206.5PV2+++A
26228.1PV1+++AS
245248.9PV1+++A
1,451261.3PV1+++A
966296.1PV2+++A
1,228393.4PV1+++A
1,494427.5PE6a/b ins 18;A20+++A
324568.1PV2+++A
1,523685PE6a;A19+++A
584714.1PE17;A20+++A
B56731.5PV3a/b+++A
563879.2PV1+++AS
1,4591,144.1PV1+++A
5911,226.2PV3a/b+++A
9641,260.6PV2+++A
3471,341.8PV1+++A
B361,422.8PV1+++A
1,1411,573.7PV1+++A

NOTE: P, positive; N, negative; Pathol., pathology; A, adenocarcinoma; AS, adenosquamous carcinoma. V1,E13;A20, V2,E20;A20, V3a/b, E6a/b;A20.

  • aExpression in 3′ portion of ALK mRNA relative to 5′ portion.